The prognostic role of PD-L1 expression and the presence of polyomavirus in Merkel cell carcinoma cases
Open Access
- 4 January 2024
- journal article
- research article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 19 (1) , 1-10
Abstract
Background: Merkel cell carcinoma (MCC) comprises a rare malignant primary skin tumor presenting neuroendocrine differentiation. Recently, agents blocking the programmed cell death protein 1 and programmed cell death protein ligand 1 pathway (PD-1/PD-L1) have demonstrated objective and durable tumor regressions in patients presenting advanced MCC. This study aimed to describe the sociodemographic, clinical, and histopathological characteristics of MCC patients, also assessing the prevalence of PD-L1 expression and Merkel cell Polyomavirus (MCPyV), as well as their prognostic roles. Methods: Data from patients diagnosed with MCC between 1996 and 2019 at a reference cancer center in Rio de Janeiro, southeastern Brazil, were evaluated in a retrospective study. Tumor samples were tested for MCPyV and PD-L1 employing immunohistochemistry. Survival analyses were carried out employing the Kaplan–Meier method and curves were compared using the log-rank test. A multiple semiparametric Cox model was used. Values p < 0.05 were considered significant. Results: A total of 65 patients were included in the study, with a mean age at diagnosis of 72 (standard deviation 13.9). A total of 56.9% (37/65) of the patients were male, 86.2% (56/65) were white, and 56.9% (37/64) were illiterate or with incomplete elementary school. MCPyV immunohistochemistry was positive in 29 cases (44.6%) and PD-L1 positivity was ≥ 1% in 42 cases (64.6%). Significant associations between MCPyV and PD-L1 expression ≥ 1% (p = 0.003) and PD-L1 expression ≥ 5% (p = 0.005) were noted. Concerning the multivariate analysis, only education level and advanced MCC stage indicated statistically significant worse progression-free survival. Regarding overall survival (OS), being male, education level and advanced stage comprised risk factors. The estimated OS at 60 months for stages I to III was of 48.9% and for stage IV, 8.9%. Conclusions: This is the first large Brazilian cohort to assess the prevalence of MCPyV in MCC tumors, as well as PD-L1 expression and their associations. No correlations were noted between MCPyV infection or PD-L1 expression and survival rates.Keywords
This publication has 42 references indexed in Scilit:
- Merkel Cell Polyomavirus Expression in Merkel Cell Carcinomas and Its Absence in Combined Tumors and Pulmonary Neuroendocrine CarcinomasAmerican Journal of Surgical Pathology, 2009
- Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell CarcinomaJNCI: Journal of the National Cancer Institute, 2009
- Merkel Cell Polyomavirus Is More Frequently Present in North American than Australian Merkel Cell Carcinoma TumorsJournal of Investigative Dermatology, 2009
- Merkel cell carcinomaCancer, 2008
- Variação de peso, grau de escolaridade, saneamento básico, etilismo, tabagismo e hábito alimentar pregresso em pacientes com cancêr de estômagoArquivos de Gastroenterologia, 2008
- Clonal Integration of a Polyomavirus in Human Merkel Cell CarcinomaScience, 2008
- Merkel Cell Carcinoma: Does Tumor Size or Depth of Invasion Correlate With Recurrence, Metastasis, or Patient Survival?The Laryngoscope, 2006
- Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markersHistopathology, 2005
- Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single InstitutionJournal of Clinical Oncology, 2005
- Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methodsBritish Journal of Cancer, 2003